Key Financial Data Of Reporting Company

WAKAMOTO PHARMACEUTICAL CO.,LTD. - Filing #7537523

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
2023-07-01 to
2023-09-30
As at
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
3,618,388,000 JPY
8,660,379,000 JPY
4,019,650,000 JPY
Ordinary profit (loss)
-319,840,000 JPY
242,574,000 JPY
-27,945,000 JPY
Profit (loss)
-222,762,000 JPY
138,256,000 JPY
-21,520,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
Share capital
3,395,887,000 JPY
3,395,887,000 JPY
3,395,887,000 JPY
Total number of issued shares
34,838,000 xbrli:shares
34,838,000 xbrli:shares
34,838,000 xbrli:shares
Net assets
12,032,325,000 JPY
11,906,669,000 JPY
11,579,077,000 JPY
Total assets
15,811,544,000 JPY
15,711,553,000 JPY
14,737,616,000 JPY
Dividend paid per share
3.00
Basic earnings (loss) per share
-6.42
-9.32
3.98
-0.62
-0.48
Diluted earnings per share
Equity-to-asset ratio
0.7609 xbrli:pure
0.7578 xbrli:pure
0.7857 xbrli:pure
Net cash provided by (used in) operating activities
108,673,000 JPY
631,920,000 JPY
254,291,000 JPY
Net cash provided by (used in) investing activities
78,066,000 JPY
17,131,000 JPY
149,649,000 JPY
Net cash provided by (used in) financing activities
-104,307,000 JPY
-1,615,000 JPY
-1,031,000 JPY
Cash and cash equivalents
3,961,757,000 JPY
3,879,325,000 JPY
3,634,798,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.